Sofosbuvir (GS-7977), a pan-genotype, direct-acting antiviral for hepatitis C virus infection
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sofosbuvir (GS-7977), a pan-genotype, direct-acting antiviral for hepatitis C virus infection
Authors
Keywords
-
Journal
Expert Review of Anti-Infective Therapy
Volume 11, Issue 12, Pages 1269-1279
Publisher
Informa UK Limited
Online
2013-11-12
DOI
10.1586/14787210.2013.855126
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Increasing Burden of Mortality From Viral Hepatitis in the United States Between 1999 and 2007
- (2013) Kathleen N. Ly et al. ANNALS OF INTERNAL MEDICINE
- Sofosbuvir with pegylated interferon alfa-2a and ribavirin for treatment-naive patients with hepatitis C genotype-1 infection (ATOMIC): an open-label, randomised, multicentre phase 2 trial
- (2013) Kris V Kowdley et al. LANCET
- Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised, double-blind, phase 2 trial
- (2013) Eric Lawitz et al. LANCET INFECTIOUS DISEASES
- How to optimize HCV therapy in genotype 1 patients with cirrhosis
- (2013) Marc Bourlière et al. LIVER INTERNATIONAL
- Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options
- (2013) Ira M. Jacobson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nucleotide Polymerase Inhibitor Sofosbuvir plus Ribavirin for Hepatitis C
- (2013) Edward J. Gane et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
- (2013) Eric Lawitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- New Pharmacotherapy for Hepatitis C
- (2012) D N Assis et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Cyclosporine versus Tacrolimus Treated Liver Transplant Recipients with Chronic Hepatitis C: Outcomes Analysis of the UNOS/OPTN Database
- (2011) W. D. Irish et al. AMERICAN JOURNAL OF TRANSPLANTATION
- An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases
- (2011) Marc G. Ghany et al. HEPATOLOGY
- 1370 ONCE DAILY DUAL-NUCLEOTIDE COMBINATION OF PSI-938 AND PSI-7977 PROVIDES 94% HCVRNA
- (2011) E. Lawitz et al. JOURNAL OF HEPATOLOGY
- The global health burden of hepatitis C virus infection
- (2011) Francesco Negro et al. LIVER INTERNATIONAL
- Boceprevir for Untreated Chronic HCV Genotype 1 Infection
- (2011) Fred Poordad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
- (2011) Ira M. Jacobson et al. NEW ENGLAND JOURNAL OF MEDICINE
- PSI-7851, a Pronucleotide of -D-2'-Deoxy-2'-Fluoro-2'-C-Methyluridine Monophosphate, Is a Potent and Pan-Genotype Inhibitor of Hepatitis C Virus Replication
- (2010) A. M. Lam et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evolving epidemiology of hepatitis C virus
- (2010) D. Lavanchy CLINICAL MICROBIOLOGY AND INFECTION
- Increasing Prevalence of HCC and Cirrhosis in Patients With Chronic Hepatitis C Virus Infection
- (2010) Fasiha Kanwal et al. GASTROENTEROLOGY
- Hepatitis C virus directly acting antivirals: current developments with NS3/4A HCV serine protease inhibitors
- (2010) S. Naggie et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Diagnosis, management, and treatment of hepatitis C: An update
- (2008) Marc G. Ghany et al. HEPATOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started